EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx, Doxil) at a 6-week interval in patients with metastatic breast cancer. European Organization for Research and Treatment of Cancer.
Ann Oncol
; 13(6): 910-8, 2002 Jun.
Article
em En
| MEDLINE
| ID: mdl-12123337
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Doxorrubicina
Idioma:
En
Ano de publicação:
2002
Tipo de documento:
Article